Clear Scientific has received continued support to develop a biotherapeutic agent

Clear Scientific
Aug 1, 2021
1 min read

Updated: Mar 7, 2022

Cambridge, Massachusetts | August 2021

Clear Scientific has received continued support from a government agency to develop a biotherapeutic agent to scavenge and sequester nerve agents in the human body. This effort is focused on scale up and testing of a longer-lasting enzyme that can act as a prophylactic and/or therapeutic against pesticides and nerve agent poisoning. This technology has the potential to provide multi-day or week-long protection.

Recent Posts

See All

Clear Scientific's Executive Vice President presents at the 18th Annual Conference in Behavior, Biology, and Chemistry Translational Research in Substance Use Disorders

San Antonio, TX | March 2025 On March 23, 2025, Dr. Xinhua Li, Executive Vice President of Clear Scientific Inc., a clinical-stage...

National Institute on Drug Abuse Highlights need for sequestrants like Clear Scientific’s First-in-Class Methamphetamine Antidote CS-1103 in 2025 Outlook

Cambridge MA | Feb 2025 In their blog entry Reflecting on NIDA’s 50th year and looking to 2025 , published January 8, 2025, the National...

Clear Scientific Presents at the Advances in Developing Medical Countermeasures Against Opioids and Drug-Induced Respiratory Depression Conference

Rockville MD | Dec 2024 On December 17-18, 2024, Dr. Xinhua Li and Dr. Mitch Zakin of Clear Scientific Inc., a clinical-stage...

Clear Scientific has received continued support to develop a biotherapeutic agent

Recent Posts

Comentários

Contact Us